It's taking what is historically a pay-and-chase system and making it more of a threshold review," said Michael Anderson.

CARDAMYST™ (etripamil) nasal spray launch for PSVT is gaining traction; breadth of unique prescribers supports potential future adoptionExpress Scripts national formulary coverage secured as company ...

Over 77,000 households in Delhi have completed self-enumeration for Census 2027, with northeast Delhi leading participation ...

ADI Foundation and Exodus Movement, Inc. (NYSE American: EXOD) today announced native support for the ADI token and ADI ...